TOWA PHARMACEUTICAL CO.,LTD. (4553) Other
Market cap
¥199.6B
P/E ratio
9x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Return on Assets | - | - | - | - | 5.5 | 3.5 | 3.8 | 7.4 | 7 | 5.9 | 5.5 | 0.6 | 4 | 4.2 | 1.1 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 1,567 | 1,696 | 1,879 | 2,060 | 2,203 | 2,408 | 2,449 | 2,472 | 3,325 | 3,456 | 4,078 | 4,298 | 4,588 | 4,788 | 4,923 |
| Total payout ratio | - | - | - | 11.5 | 88.5 | 27.9 | - | 11.6 | 14.3 | 15.5 | 15.2 | 140.8 | 18.3 | 15.6 | 75 |